Application of animal-derived lysozyme dimer in preparation of preparation for inhibiting porcine reproductive and respiratory syndrome virus and feed additive

Through feed additives combined with animal-derived lysozyme dimers, traditional Chinese medicine extracts and probiotics, the proliferation and resistance of pig blue ear viruses are solved, effective disease inhibition and rapid treatment are achieved, and biosafety and economic advantages are provided. .

CN119014492APending Publication Date: 2024-11-26HENAN UNIV OF SCI & TECH
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411130334.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-16
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

The prior art is difficult to effectively inhibit or kill pig blue ear virus (PRRSV), resulting in poor prevention and treatment of pig blue ear disease, and the abuse of common drugs leads to drug resistance and drug resistance problems.

Method used

Feed additives prepared in combination with animal-derived lysozyme dimers and traditional Chinese medicine extracts and probiotics are added to the feed to inhibit the proliferation and development of pig blue ear virus and avoid drug resistance and drug resistance.

Benefits of technology

This feed additive can effectively inhibit the proliferation of pig blue ear virus in cells, quickly treat the disease, have no recurrence of diseases for a long time, and has high biosafety and low cost, avoiding the abuse of antibiotics and antiviral drugs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119014492A_ABST
    Figure CN119014492A_ABST
Patent Text Reader

Abstract

The invention relates to application of an animal-derived lysozyme dimer in preparation of a preparation for inhibiting porcine reproductive and respiratory syndrome virus and a feed additive, and belongs to the technical field of feed additive preparations. According to the method, MARC-145 cells are taken as experimental subjects, animal-derived lysozyme and animal-derived lysozyme dimers are respectively used for treating the MARC-145 cells, the treated MARC-145 cells and PRRSV are co-cultured, then cell activity indexes are detected, and the anti-PRRSV effect of the lysozyme is evaluated by using an immunofluorescence method. The result shows that the animal source lysozyme monomer does not have the effect of effectively inhibiting the proliferation of the PRRSV in the MARC-145 cells, but the animal source lysozyme dimer can effectively inhibit the proliferation of the PRRSV in the MARC-145 cells, so that the animal source lysozyme dimer can be prepared into the preparation for inhibiting the porcine reproductive and respiratory syndrome virus. Moreover, the animal source lysozyme is derived from eggs, is high in biological safety, and has the advantages of being low in cost, safe and green.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to application of animal-derived lysozyme dimer in preparing a preparation for inhibiting porcine blue ear virus and a feed additive, belonging to the technical field of feed additive preparations. Background Art

[0002] Porcine reproductive and respiratory syndrome (PRRS), also known as blue ear disease, was once called "mysterious pig disease", "new pig disease", "porcine epidemic abortion and respiratory syndrome", "swine plague", etc. It is a relatively common and highly harmful infectious disease. my country has classified it as a Category II infectious disease. Blue ear disease is usually a symptom of piglet and sow herds infected with the Porcine reproductive and respiratory syndrome virus (PRRSV). Clinically, it mainly manifests as reproductive disorders in sows and breathing difficulties in piglets. The incubation period of the disease varies greatly. The incubation period of PRRS in susceptible pig herds after the infection is introduced is as short as 3 days and as long as 37 days.

[0003] PRRSV is an enveloped single-stranded positive-strand RNA virus that can infect pigs of a wide age range, with the most severe symptoms in piglets and pregnant sows. After infection, piglets experience breathing difficulties, and some also have neurological symptoms such as muscle tremors and limb paralysis, with an incidence rate of 100% and a mortality rate of over 50%. Pregnant sows mainly experience reproductive dysfunction such as premature birth, abortion, stillbirth, mummified fetuses or weak piglets, with an abortion rate of over 30%. At the same time, there are clinical symptoms such as obvious fever, conjunctival inflammation, obvious eyelid edema, wheezing and coughing. The ears and skin of sick pigs turn blue (cyanosis). Some sick pigs may also show neurological symptoms such as muscle tremors, unstable standing, hindquarter weakness, and ataxia. At present, the disease has shown a high incidence trend in my country, showing an endemic phenomenon, causing serious losses to the pig industry.

[0004] At present, the main prevention and treatment methods for blue ear disease are as follows:

[0005] (1) Vaccine immunization: There are mainly inactivated vaccines, attenuated live vaccines, DNA vaccines, recombinant subunit vaccines, live vector vaccines, gene-deficient vaccines and synthetic peptide vaccines. Vaccine immunization has a certain preventive and therapeutic effect, but the PRRSV genome mutates rapidly, the vaccine cross-protection effect is poor, and in actual production, it is often mixed with immunosuppressive diseases such as swine fever and circovirus, resulting in poor prevention effect;

[0006] (2) Western medicine treatment: mainly antibiotics (such as ceftiofur sodium, roxithromycin, florfenicol, ciprofloxacin, gentamicin) and antiviral drugs (such as ribavirin, adenosine, iodine, famciclovir, acyclovir, amantadine, rimantadine). The rational use of antibiotics can control secondary bacterial diseases, but abuse will deepen the immune suppression of pigs against PRRS and cause the disease to worsen. Antiviral drugs are effective in the adsorption, biosynthesis, assembly, maturation and release of some viruses, but are not sensitive to PRRSV and have poor prevention and control effects.

[0007] (3) Traditional Chinese medicine treatment: mainly single Chinese medicine (such as hypericin, chlorogenic acid components of honeysuckle, extracts of agarwood, scutellaria polysaccharides, dandelion polysaccharides, purslane polysaccharides, astragalus polysaccharides, sargassum polysaccharides, yam polysaccharides) and compound Chinese medicine (such as Xiexin Decoction, Huanglian Jiedu Decoction, Qingwen Baidu Powder, Qilian Powder, Improved Yupingfeng Powder, Mahuang Gancao Decoction, Improved Bazhen Powder, Wuming Gaore Powder), which have few toxic and side effects, low drug resistance, antibacterial and anti-inflammatory effects, inhibition of viral proliferation, and enhancement of body immunity. However, the use of single Chinese medicine for treatment has the disadvantages of large dosage and long treatment cycle.

[0008] (4) Comprehensive prevention and control: Strengthening pig farm management (such as vaccination, strict disinfection, reasonable feeding, and effective isolation), improving the effectiveness of vaccination (such as reasonable selection of vaccines, attention to immunization procedures, and reasonable arrangement of vaccination sequence and time), and conducting disease monitoring are the guarantees for various prevention and control measures to achieve good results. Any treatment method needs to be coordinated with comprehensive prevention and control measures.

[0009] In summary, blue ear disease has caused serious losses to the pig industry at home and abroad, and the current prevention and control measures are still not very effective in preventing and controlling the disease. Therefore, continuing to explore safe and effective ingredients that can inhibit or kill PRRSV remains an urgent problem to be solved. Summary of the invention

[0010] The first purpose of the present invention is to provide an application of an animal-derived lysozyme dimer in the preparation of a preparation for inhibiting porcine reproductive and respiratory syndrome virus, thereby providing a safe substance that can effectively inhibit porcine reproductive and respiratory syndrome virus for the prior art.

[0011] The second object of the present invention is to provide a feed additive, which provides a safe and effective preparation for treating blue ear disease in pigs in the prior art.

[0012] In order to achieve the above-mentioned object, the technical scheme of the present invention for using animal-derived lysozyme dimer in the preparation of a preparation for inhibiting porcine blue ear virus is:

[0013] Application of animal-derived lysozyme dimer in the preparation of preparations for inhibiting porcine blue ear virus.

[0014] The beneficial effect of the above technical scheme is that the application of the animal-derived lysozyme dimer of the present invention in the preparation of a preparation for inhibiting porcine blue ear virus is an invention of a new use of a known product. The present invention uses MARC-145 cells as the experimental object, and treats the MARC-145 cells with animal-derived lysozyme and animal-derived lysozyme dimer respectively, and then co-cultures with PRRSV, then detects the cell viability index, and evaluates the anti-PRRSV effect of lysozyme by immunofluorescence. The results show that the animal-derived lysozyme monomer does not have an effective effect of inhibiting the proliferation of PRRSV in MARC-145 cells, while the animal-derived lysozyme dimer can effectively inhibit the proliferation of PRRSV in MARC-145 cells, indicating that the animal-derived lysozyme dimer can be prepared into a preparation for inhibiting porcine blue ear virus. Moreover, animal-derived lysozyme comes from eggs, has high biological safety, and has the advantages of low cost, safety, and greenness.

[0015] As a further improvement, the preparation is a preparation for inhibiting the proliferation of porcine reproductive and respiratory syndrome virus in cells.

[0016] As a further improvement, the cells are MARC-145 cells.

[0017] In order to achieve the above object, a technical solution of a feed additive in the present invention is:

[0018] A feed additive, comprising an animal-derived lysozyme dimer, a Chinese medicine extract, and probiotics; the Chinese medicine is selected from one or two of astragalus, dandelion, purslane, and honeysuckle; and the probiotics is selected from one of lactobacillus, bacillus subtilis, and bacillus licheniformis.

[0019] The beneficial effect of the above technical scheme is that: the present invention finds that the combination of animal-derived lysozyme dimer, Chinese medicine extract and probiotics is prepared into a feed additive, and added to the feed, which can effectively inhibit the continued development of the condition of pigs suffering from blue ear disease, and quickly treat them in a short time, and there is no phenomenon of recurrence of the disease for a long time. The feed additive of the present invention can effectively treat blue ear disease in pigs, and its ingredients do not contain antibiotics or antiviral drugs, and can effectively improve the drug resistance and drug tolerance of pigs caused by the abuse of antibiotics or antiviral drugs. Moreover, the various components in the feed additive of the present invention have the advantages of high biosafety, and are widely available, low cost, and are conducive to large-scale promotion and use.

[0020] Specifically, lysozyme has antibacterial, anti-inflammatory, antioxidant functions, and can improve the body's immune ability. Lysozyme is a nonspecific immune factor in animals, and participates in multiple immune responses: for example, it improves the phagocytic function of macrophages; binds to bacterial lipopolysaccharides to reduce the toxic side effects of endotoxins; induces and regulates the synthesis and secretion of other immune factors, etc. Lysozyme can not only effectively inhibit bacterial reproduction, but also effectively relieve inflammatory responses.

[0021] The raw materials of the Chinese herbal medicine extract are selected from astragalus, dandelion, purslane or honeysuckle.

[0022] (1) Astragalus is a traditional Chinese medicine. Its main components include astragalus polysaccharides, saponins (such as astragaloside, isoastragaloside, etc.), flavonoids (such as quercetin, kaempferol, etc.), amino acids, trace elements, etc. Among them, astragalus polysaccharides are the most important biologically active substances in astragalus. Experiments have shown that when pigs are fed astragalus polysaccharides while being immunized with PRRSV inactivated vaccine, the level of antibodies against blue ear disease virus is significantly increased. Other studies have shown that astragalus polysaccharides can enhance humoral immunity and cellular immune response functions.

[0023] (2) Dandelion or purslane has good immunomodulatory function, and has antiviral, anti-endotoxin, anti-inflammatory, antibacterial and immune regulating effects. Dandelion or purslane can enhance the mononuclear macrophage system and significantly enhance the function of antibody-forming cells. In the nonspecific immunity of cells in which dandelion or purslane participates, it can promote the secretion and phagocytic function of peritoneal macrophages.

[0024] (3) The main active ingredients of honeysuckle include organic acids, flavonoids, volatile oils, iridoid glycosides and triterpenoid saponins. The most important organic acid is chlorogenic acid, a phenylpropanoid compound produced by plants through the shikimic acid pathway during aerobic respiration. It has multiple effects such as anti-inflammatory, antibacterial and antiviral. Honeysuckle extract can improve the immunity of weaned piglets, improve the gastrointestinal health of weaned piglets, and improve the growth performance of weaned piglets.

[0025] The probiotics are selected from Lactobacillus, Bacillus subtilis or Bacillus licheniformis.

[0026] (1) After lactobacilli enter the small intestine through the surrounding environment and the piglet's body, they quickly form a lactobacillus flora, which can maintain the normal small intestinal flora. At the same time, lactobacilli can also produce hydrogen peroxide. Studies have shown that hydrogen peroxide can promote Fe 2+ Combined with lactobacillus trypsin, so that pathogenic bacteria cannot directly obtain Fe from the body 2+ , effectively inhibit the growth of pathogenic bacteria in the piglet digestive tract, eliminate toxicity to piglets, reduce piglet digestive tract diseases, strengthen the immune function of the intestines of weaned piglets, prevent mutations in the intestinal tissues of weaned piglets, and thus promote the healthy development of the intestines of weaned piglets.

[0027] (2) After Bacillus subtilis enters the intestine, it can increase the activity of digestive enzymes in the body and secrete a variety of enzymes to promote the decomposition of starch, protein and fat, inhibit anti-nutritional factors in feed, and improve the production performance of animals. At the same time, it can regulate the growth environment of intestinal flora, produce bacteriocins and other antibacterial substances, inhibit the colonization of pathogenic microorganisms in the intestine, prevent pathogenic microorganisms from producing toxins that damage intestinal villi, and maintain the integrity of the intestinal barrier, thereby improving the intestinal health of animals and improving their ability to digest and absorb nutrients.

[0028] (3) Bacillus licheniformis can protect the host from oxidative stress by producing antioxidant enzymes, thereby improving the body's antioxidant activity. It can also enhance the integrity of the mucosal barrier through immunomodulatory effects, thereby maintaining the intestinal health of piglets.

[0029] As a further improvement, the feed additive includes vitamin C; the mass ratio of the animal-derived lysozyme dimer to vitamin C is (3-5): (0.15-0.2).

[0030] Specifically, vitamin C, also known as ascorbic acid, is a nutrient required for the formation of bone blood vessels, cartilage, muscle and collagen, and is also crucial to the body's healing process. Vitamin C can also help the body absorb and store iron. When livestock and poultry lack vitamin C, they are prone to scurvy. The reason is that vitamin C deficiency leads to insufficient collagen, which will lead to increased intercellular spaces, increased permeability and fragility of microvessels, and easy rupture and bleeding. In severe cases, internal bleeding occurs. Vitamin C has an antioxidant effect and can protect the unsaturated fatty acids of cells from being oxidized into peroxides. Therefore, vitamin C has a protective cell and anti-aging effect. Adding vitamin C to the feed can reduce the secretion of glucocorticoids, avoid immunosuppression caused by excessive secretion concentrations, and thus improve stress resistance.

[0031] Preferably, the mass ratio of the animal-derived lysozyme dimer, the traditional Chinese medicine extract and the probiotics is (3-5): (0.5-1): (1-2); further preferably, the mass ratio of the animal-derived lysozyme dimer, the traditional Chinese medicine extract and the probiotics is (3-5): 1:2.

[0032] As a further improvement, the feed additive includes γ-aminobutyric acid; the mass ratio of the animal-derived lysozyme dimer to γ-aminobutyric acid is (3-5): (0.5-1).

[0033] Specifically, γ-aminobutyric acid, as a very important consistent neurotransmitter, is very common in animals and plants. It has the functions of improving liver and kidney, lowering blood pressure, calming nerves and anticonvulsant, and can enhance the body's exercise tolerance, antioxidant capacity, reproductive capacity and immune function. γ-aminobutyric acid can regulate the feeding center and guide the feeding behavior of livestock and poultry to increase the feed intake of livestock and poultry. At the same time, γ-aminobutyric acid can regulate the release of adrenal cortex hormones by regulating the hypothalamus-pituitary-adrenal axis, improve the immunity of livestock and poultry, and has a very good anti-stress effect. At the same time, γ-aminobutyric acid has an effective inhibitory effect on the secretion of somatostatin in the digestive tract of livestock and poultry, and can also promote the effective secretion of IgA in saliva, thereby enhancing the body's ability to resist the invasion of pathogens and enhancing the body's immunity.

[0034] As a further improvement, the feed additive includes a biologically acceptable carrier; the carrier is selected from one of light calcium carbonate, calcium chloride, tricalcium phosphate, monocalcium phosphate, calcium lactate, calcium gluconate, calcium hydrogen phosphate, wheat bran, corn cob powder, saccharin, sorbitol, saccharin calcium, saccharin sodium, and monosodium glutamate.

[0035] As a further improvement, the mass ratio of the animal-derived lysozyme dimer to the carrier is (3-5): (1.5-3.8).

[0036] As a further improvement, the number of viable bacteria in the probiotics is ≥ 10×10 11 Pieces / g. BRIEF DESCRIPTION OF THE DRAWINGS

[0037] Figure 1 The effect of lysozyme dimer on cell viability against PRRSV in Example 1 of the present invention (in the figure, A: MTT method was used to detect the effect of lysozyme dimer on cell viability of MARC-145 cells infected with PRRSV for 12 hours; B: MTT method was used to detect the effect of lysozyme dimer on cell viability of MARC-145 cells infected with PRRSV for 24 hours; C: MTT method was used to detect the effect of lysozyme dimer on cell viability of MARC-145 cells infected with PRRSV for 36 hours; D: MTT method was used to detect the effect of lysozyme dimer on cell viability of MARC-145 cells infected with PRRSV for 48 hours, and the difference between different superscript letters represents a significant difference (P<0.05));

[0038] Figure 2The effect of lysozyme monomer on cell viability against PRRSV in Example 1 of the present invention (in the figure, A: MTT method was used to detect the effect of lysozyme monomer on cell viability of MARC-145 cells infected with PRRSV for 12 hours; B: MTT method was used to detect the effect of lysozyme monomer on cell viability of MARC-145 cells infected with PRRSV for 24 hours; C: MTT method was used to detect the effect of lysozyme monomer on cell viability of MARC-145 cells infected with PRRSV for 36 hours; D: MTT method was used to detect the effect of lysozyme monomer on cell viability of MARC-145 cells infected with PRRSV for 48 hours, and the difference between different superscript letters represents a significant difference (P<0.05));

[0039] Figure 3 The effects of lysozyme dimer and lysozyme monomer on anti-PRRSV in Example 1 of the present invention (in the figure, A: immunofluorescence detection of the effect of lysozyme dimer on the optical density value of MARC-145 cells infected with PRRSV; B: immunofluorescence detection of the effect of lysozyme monomer on the optical density value of MARC-145 cells infected with PRRSV; C: immunofluorescence detection of lysozyme dimer on the optical density value of MARC-145 cells infected with PRRSV; D: immunofluorescence detection of lysozyme monomer on the optical density value of MARC-145 cells infected with PRRSV. The difference between different superscript letters represents a significant difference (P<0.05)). DETAILED DESCRIPTION

[0040] Porcine reproductive and respiratory syndrome, also known as blue ear disease, is highly contagious through contact and has the characteristics of local epidemics. It is classified as a Class II infectious disease in my country. The incubation period varies greatly. The incubation period of RRSV in susceptible pigs after the introduction of infection is as short as 3 days and as long as 37 days. Its clinical symptoms vary greatly and are affected by the virus strain, immune status, feeding and management factors, and environmental conditions. Low-virulence strains can cause epidemics in pigs without clinical symptoms, while high-virulence strains can cause serious clinical diseases. However, there are no very effective immune prevention measures for this disease. Although commercialized PRRS attenuated vaccines and inactivated vaccines have been launched at home and abroad, and there are also officially approved inactivated vaccines in China, the phenomenon of enhanced virulence of PRRS attenuated vaccines and safety issues are increasingly causing people's concerns. The use of chemical drugs is prone to drug resistance and tolerance.

[0041] Based on this, the present invention provides the use of animal-derived lysozyme dimers in the preparation of preparations for inhibiting porcine blue ear virus. The present invention proves through in vitro experiments that the co-culture of animal-derived lysozyme dimers with PRRSV cells can significantly improve cell viability, and can restore the reduced level of viability of PRRSV-infected cells to normal levels, indicating that animal-derived lysozyme dimers have the effect of resisting PRRSV-induced cell viability reduction. At the same time, experiments also prove that animal-derived lysozyme dimers can effectively inhibit the proliferation of PRRSV in cells. This fully demonstrates that animal-derived lysozyme dimers can be used to prepare preparations for inhibiting porcine blue ear virus, enriching the practical application range of lysozyme dimers.

[0042] Furthermore, the present invention provides a feed additive. The present invention finds that a feed additive prepared by combining animal-derived lysozyme dimers, Chinese medicine extracts, and probiotics and added to feed can effectively inhibit the continued development of the condition of pigs suffering from blue ear disease, and quickly treat them in a short period of time, and there is no recurrence of the disease for a long time. The feed additive of the present invention can effectively treat blue ear disease in pigs, and its ingredients do not contain antibiotics or antiviral drugs, and can effectively improve the drug resistance and drug tolerance of pigs caused by the abuse of antibiotics or antiviral drugs. Moreover, the various components in the feed additive of the present invention have the advantages of high biosafety, and are widely available and low in cost, which is conducive to large-scale promotion and use.

[0043] The present invention is further described below in conjunction with specific embodiments, but the protection scope of the present invention is not limited thereto; however, these embodiments are only examples and do not constitute any limitation on the scope of the present invention. The details and forms of the present invention may be modified or replaced without departing from the spirit and scope of the present invention, but these modifications and replacements fall within the protection scope of the present invention. The experimental methods in the following embodiments are conventional methods unless otherwise specified. The experimental materials used in the following embodiments, unless otherwise specified, were purchased from conventional biochemical reagent manufacturers.

[0044] Some of the biological materials, experimental reagents, experimental equipment, etc. involved in the following embodiments and experimental examples are briefly introduced as follows:

[0045] Biomaterials:

[0046] Cell information: MARC-145 (monkey embryonic epithelial cells); culture medium: 89% DMEM+10% FBS+1% P / S.

[0047] Drug preparation:

[0048] Lysozyme monomer (Hunan Huibaishi Biotechnology Co., Ltd., CAS: 12650-88-3) was prepared into 5 mg / mL stock solution with sterile water and stored at room temperature for later use. When used, it was diluted to the required concentration with the corresponding culture medium.

[0049] Lysozyme dimer (Zhengda Biotechnology, trade name: Zhengrongkang Lysozyme) was prepared into 1 mg / mL stock solution with 0.1M pH 6.6 citric acid-sodium citrate buffer and stored at room temperature for later use. When used, it was diluted to the required concentration with the corresponding culture medium.

[0050] 1. Specific examples of the use of the animal-derived lysozyme dimer of the present invention in the preparation of a preparation for inhibiting porcine reproductive and respiratory syndrome virus:

[0051] The present invention uses MARC-145 cells as experimental objects, treats MARC-145 cells with lysozyme and lysozyme dimer respectively, and then co-cultures with PRRSV, then detects cell viability indicators, and uses immunofluorescence to evaluate the anti-PRRSV effect of lysozyme. The specific implementation operations are as follows:

[0052] Example 1

[0053] 1. Cell recovery

[0054] The MARC-145 cells were taken out of liquid nitrogen, quickly placed in a 37°C water bath, and the cryopreservation tube was gently shaken to dissolve the cryopreservation solution; after dissolution, the cells were transferred to a centrifuge tube containing 5 mL of culture medium, and the cells were collected by centrifugation, centrifuged at 1000 rpm for 5 min at room temperature, and the supernatant was discarded; the cells were resuspended in complete culture medium containing fetal bovine serum, inoculated into a culture dish, gently blown to mix, and cultured at 37°C and 5% CO2 saturated humidity.

[0055] 2. Cell passaging and expansion culture (adherent cells)

[0056] When the cell density reaches 80%, the cells are passaged, the culture medium is discarded, and the cells are washed once with PBS; 1-2 mL of 0.25% trypsin is added to digest the cells, and the cells are observed under a microscope. After digestion for 1-2 minutes, the cells can be seen to separate from each other and become round, indicating that the digestion is complete; the trypsin is quickly discarded, complete culture medium is added, and the cells are blown to make a single cell suspension, which is passaged at a ratio of 1:3 and expanded at 37°C and 5% CO2 saturated humidity.

[0057] 3. Cell grouping and experimental treatment

[0058] MARC-145 cells in the logarithmic growth phase and in good growth condition were taken at 2×10 3 Each well was inoculated with 96-well plates, and a blank group was set up at the same time, and cultured at 37°C overnight (100 μL of sterile PBS was added to the wells around the cell wells); the cells were treated according to different grouping conditions, and then cultured in a 37°C, 5% CO2 incubator. Two experiments were carried out in this embodiment, and the experimental design is shown in Table 1.

[0059] Experiment 1: After lysozyme and lysozyme dimer were pretreated with cells for 2 hours, the cells were co-cultured with the virus for 12 hours, 24 hours, 36 hours and 48 hours, respectively, and the cell viability index was detected using the CCK-8 method. The detection method is as follows:

[0060] ① 1×10 5 Cells / 100 μL were inoculated into 96-well plates, and the same amount of culture medium was added to the control wells and incubated at 37°C with 5%

[0061] Culture in CO2 cell culture incubator;

[0062] ② After the cells adhered to the wall, 10 μL of CCK-8 solution was added to each well at the corresponding time point and cultured in the incubator for another hour;

[0063] ③Measure the absorbance at 450nm with an enzyme-labeled instrument.

[0064] Experiment 2: Lysozyme and lysozyme dimer were pretreated with cells for 2 hours, and then co-cultured with the virus for 48 hours to detect the anti-PRRSV effect of lysozyme by immunofluorescence. The detection method is as follows:

[0065] ① PLA pretreated coverslips and placed in 24-well plates;

[0066] ②Count the cells after trypsin digestion;

[0067] ③Select 2×10 5 The cells were seeded into culture plates at the same density and intervention treatments were performed the next day;

[0068] ④ Take the treated cell slides, move them into a 24-well plate, and soak them in cold PBS for no more than 3 minutes;

[0069] ⑤ Add 4% paraformaldehyde to each slide, fix on ice for 15 minutes, and cover evenly horizontally;

[0070] ⑥ Wash with cold phosphate buffer saline (PBS), repeat twice for 5 minutes, and wipe the edge of the slide dry;

[0071] ⑦ Add blocking serum, place in a wet box at 37°C for 60 minutes, and wipe off the blocking solution with filter paper;

[0072] ⑧ Add standard diluted primary antibody onto the slide, incubate in a humidified box at 4°C overnight, then wash with PBS for 3 min 5 times to remove the primary antibody, and wipe off the PBS outside the specimen with filter paper;

[0073] ⑨ Add fluorescent secondary antibody, incubate in a humidified box at 37℃ for 1 hour in the dark, wash with PBS for 3 minutes, repeat 3 times to wash away the secondary antibody, and wipe off the PBS outside the specimen with filter paper;

[0074] ⑩ Add DAPI and incubate in the dark for 2 minutes to visualize the nucleus of the specimen, with blue fluorescence, and the effect is excellent. Wash with PBS, repeat 3 times for 5 minutes to wash away DAPI (4',6-diamidino-2-phenylindole), wipe off the PBS outside the specimen with filter paper; seal the slide with anti-fluorescence quencher, and immediately observe and take pictures under a fluorescence microscope.

[0075] Table 1 Cell grouping and experimental treatment

[0076]

[0077] 4. Results Analysis

[0078] (1) Test 1 results:

[0079] Depend on Figure 1 It can be seen that compared with the blank control group, the cell viability decreased significantly after 12, 24, 36 and 48 hours of infection with PRRSV virus (P<0.05). However, after 100μg / L, 500μg / L, 800μg / L and 1000μg / L lysozyme dimer was co-cultured with the virus, the cell viability was significantly improved (P<0.05), among which 800μg / L and 1000μg / L lysozyme dimer can restore the cell viability level reduced by PRRSV infection to normal level, indicating that lysozyme dimer has the effect of resisting the reduction of cell viability caused by PRRSV.

[0080] Depend on Figure 2 It can be seen that compared with the blank control group, the cell viability decreased significantly after 12, 24, 36 and 48 hours after PRRSV virus infection (P<0.05). At the same time, after 100μg / L, 500μg / L, 800μg / L and 1000μg / L lysozyme monomers were co-cultured with the virus, there was no significant change in cell viability, indicating that lysozyme monomers have no effect on resisting PRRSV-induced cell viability reduction.

[0081] (2) Results of Experiment 2:

[0082] Depend on Figure 3(A, C) It can be seen that compared with the blank control group, the optical density of PRRSV in cells increased significantly after PRRSV virus infection (P<0.05). However, after 100μg / L, 500μg / L, 800μg / L and 1000μg / L lysozyme dimer was co-cultured with the virus, the optical density of PRRSV in cells decreased significantly (P<0.05), among which 1000μg / L lysozyme dimer was co-cultured with the virus, and the optical density of PRRSV in cells could be restored to normal levels. The results show that after adding lysozyme dimer to infect PRRSV, it can effectively inhibit the proliferation of PRRSV in MARC-145 cells.

[0083] Depend on Figure 3 (B, D) It can be seen that compared with the blank control group, the optical density of PRRSV in the cells increased significantly after PRRSV virus infection (P<0.05). However, after 100μg / L, 500μg / L, 800μg / L and 1000μg / L lysozyme monomers were co-cultured with the virus, the optical density of PRRSV in the cells did not change significantly. The results show that lysozyme monomers do not have the effect of inhibiting the proliferation of PRRSV in MARC-145 cells.

[0084] The results of Experiment 1 and Experiment 2 show that lysozyme dimer has the effect of inhibiting the proliferation of PRRSV in MARC-145 cells, and has obvious dose dependence. At the same time, the addition of lysozyme dimer has the effect of inhibiting the proliferation of PRRSV in MARC-145 cells. However, lysozyme monomer does not have the effect of inhibiting the proliferation of PRRSV in MARC-145 cells.

[0085] 2. Specific embodiments of a feed additive of the present invention:

[0086] Example 2

[0087] 1000g of the feed additive of the present embodiment is composed of the following ingredients:

[0088] 500g of lysozyme dimer, 100g of crude astragalus (Zhengda Biotechnology, Astragalus I), 200g of plant lactobacillus, 20g of vitamin C, and the rest are diluted to 1000g with corncob powder.

[0089] Example 3

[0090] 1000g of the feed additive of the present embodiment is composed of the following ingredients:

[0091] 500g of lysozyme dimer, 100g of honeysuckle crude product (Hebei New Century Pharmaceutical, honeysuckle crude product), 200g of Bacillus licheniformis, 20g of vitamin C, and the rest was diluted to 1000g with corncob powder.11 cfu / g.

[0092] Example 4

[0093] 1000g of the feed additive of the present embodiment is composed of the following ingredients:

[0094] 500g of lysozyme dimer, 100g of crude extracts of dandelion and purslane (Zhengda Biotechnology, crude extracts of dandelion, purslane, dandelion, and purslane), 200g of Bacillus subtilis, 20g of vitamin C, and the rest was diluted to 1000g with wheat bran. 11 cfu / g.

[0095] Example 5

[0096] 1000g of the feed additive of the present embodiment is composed of the following ingredients:

[0097] 500g of lysozyme dimer, 100g of crude astragalus (Zhengda Biotechnology, Astragalus I), 200g of Bacillus licheniformis, 50g of γ-aminobutyric acid, and the rest was diluted to 1000g with calcium hydrogen phosphate. 11 cfu / g.

[0098] Example 6

[0099] 1000g of the feed additive of the present embodiment is composed of the following ingredients:

[0100] 300g of lysozyme dimer, 100g of honeysuckle crude (Hebei New Century Pharmaceutical, honeysuckle crude), 200g of plant lactobacillus, 100g of γ-aminobutyric acid, and the rest was diluted to 1000g with wheat bran. 11 cfu / g.

[0101] Example 7

[0102] 1000g of the feed additive of the present embodiment is composed of the following ingredients:

[0103] 300g of lysozyme dimer, 100g of crude extracts of dandelion and purslane (Zhengda Biotechnology, crude extracts of dandelion, purslane and dandelion), 200g of Bacillus subtilis, 100g of γ-aminobutyric acid, and the rest was diluted to 1000g with light calcium carbonate. 11 cfu / g.

[0104] Example 8

[0105] 1000g of the feed additive of the present embodiment is composed of the following ingredients:

[0106] 300g of lysozyme dimer, 100g of crude astragalus (Zhengda Biotechnology, Astragalus I), 100g of Lactobacillus plantarum, 100g of Bacillus subtilis, 20g of vitamin C, and the rest was diluted to 1000g with corncob powder. 11 cfu / g.

[0107] Example 9

[0108] 1000g of the feed additive of the present embodiment is composed of the following ingredients:

[0109] 300g of lysozyme dimer, 100g of honeysuckle crude (Hebei New Century Pharmaceutical, honeysuckle crude), 100g of plant lactobacillus, 100g of Bacillus subtilis, 100g of γ-aminobutyric acid, and the rest was diluted to 1000g with light calcium carbonate. 11 cfu / g.

[0110] Example 10

[0111] 1000g of the feed additive of the present embodiment is composed of the following ingredients:

[0112] 300g of lysozyme dimer, 100g of crude extracts of dandelion and purslane (Zhengda Biotechnology, crude extracts of dandelion purslane), 100g of Lactobacillus plantarum, 100g of Bacillus licheniformis, 20g of vitamin C, and the rest was diluted to 1000g with wheat bran. 11 cfu / g.

[0113] Embodiment 11

[0114] 1000g of the feed additive of the present embodiment is composed of the following ingredients:

[0115] 300g of lysozyme dimer, 100g of crude astragalus (Zhengda Biotechnology, Astragalus I), 100g of Bacillus subtilis, 100g of Bacillus licheniformis, 50g of γ-aminobutyric acid, and the rest was diluted to 1000g with light calcium carbonate. 11 cfu / g.

[0116] In the above embodiments, lysozyme dimer, probiotics and crude Chinese medicine are essential ingredients, while vitamin C and γ-aminobutyric acid are optional essential ingredients, because vitamin C and γ-aminobutyric acid can both exert similar effects, both can exert anti-animal stress effects, and have a synergistic effect against porcine blue ear virus, so you only need to choose one of the two.

[0117] 3. Experimental examples for verifying the effect of the feed additive of the present invention:

[0118] Experimental Example 1

[0119] A pig farm in Xinxiang City, Henan Province, has 1,955 fattening pigs on hand.

[0120] Disease situation: This batch of fattening pigs weighed 40-50 kg and started to get sick about 10 days after being transferred from the sow farm for fattening. The number of sick pigs was 1,554, with an incidence rate of 79.5%. The symptoms of the disease were coughing and a temperature rise of 40-41 degrees. The autopsy of the dead pigs showed symptoms such as pulmonary interstitial edema, lymph node hemorrhage, and residual foam in the trachea. The treatment of tilmicosin + doxycycline + florfenicol for one week had some effect, but the disease rebounded after stopping the medication. Blood samples of 200 pigs were randomly collected and sent to the laboratory. The porcine blue ear virus antibody detection kit (enzyme-linked immunosorbent assay, Sinorecon Co., Ltd., A002) was used for testing. 158 blood samples were positive for blue ear antibodies, with an incidence rate of 79.0%. Based on the epidemiological survey and laboratory test data, the pig herd was diagnosed with blue ear disease secondary to pleuropneumonia.

[0121] The treatment plan is as follows: add 2kg / ton per ton of feed. The feed additive in Example 2 was used for 20 consecutive days. After 5 days of medication, blood samples of 200 pigs were randomly collected and sent to the laboratory. The blue ear virus antibody detection kit (enzyme-linked immunosorbent assay, Sinolikang Co., Ltd., A002) was used for detection. Six blood samples were positive for blue ear antibodies, and the incidence rate of the pig herd was significantly reduced to 3.0%. After continuing to use the drug for 15 days, all the pigs recovered, and there was no recurrence of the disease in the pig herd.

[0122] Experimental Example 2

[0123] A pig farm in Shaoxing City, Zhejiang Province, has 1,864 fattening pigs in stock.

[0124] Disease situation: The pigs were transferred from the sow farm to fatten 45-50 kg. The disease started to occur around 15 days ago. The number of affected pigs was 1,357, with an incidence rate of 73%. They showed coughing and body temperature rose to between 40 and 41 degrees. Autopsy of dead pigs showed symptoms such as pulmonary interstitial edema, residual foam in the trachea, and lymph node hemorrhage. One week of treatment with tilmicosin + doxycycline + florfenicol had some effect, but the pigs rebounded after stopping the medication. Blood samples of 200 pigs were randomly collected and sent to the laboratory. The porcine blue ear virus antibody detection kit (enzyme-linked immunosorbent assay, Sinorecon Co., Ltd., A002) was used for testing. 151 blood samples were positive for blue ear antibodies, with an incidence rate of 76%. Based on epidemiological surveys and laboratory test data, the pig herd was diagnosed with blue ear disease secondary to pleuropneumonia.

[0125] The treatment plan is as follows: add 2kg / ton per ton of feed. The feed additive in Example 3 was used for 20 consecutive days. After 5 days of medication, blood samples of 200 pigs were randomly collected and sent to the laboratory. The blue ear virus antibody detection kit (enzyme-linked immunosorbent assay, Sinolikang Co., Ltd., A002) was used for detection. Four blood samples were positive for blue ear antibodies, and the incidence rate of the pig herd was significantly reduced to 2.0%. After continuing to use the drug for 15 days, all the pigs recovered, and there was no recurrence of the disease in the pig herd.

[0126] Based on the above results, the present invention proves through in vitro experiments that the co-culture of animal-derived lysozyme dimers with PRRSV cells can significantly improve cell viability and restore the reduced viability level of PRRSV-infected cells to normal levels, indicating that animal-derived lysozyme dimers have the effect of resisting the reduction of cell viability caused by PRRSV. At the same time, experiments also prove that animal-derived lysozyme dimers can effectively inhibit the proliferation of PRRSV in cells. This fully demonstrates that animal-derived lysozyme dimers can be used to prepare preparations that inhibit porcine blue ear virus, enriching the practical application range of lysozyme dimers.

[0127] Finally, it is noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or replace some or all of the technical features therein with equivalents. However, these modifications or replacements do not cause the essence of the corresponding technical solutions to deviate from the scope of the technical solutions of the embodiments of the present invention.

Claims

1. Application of animal-derived lysozyme dimers in the preparation of preparations for inhibiting porcine reproductive and respiratory syndrome virus.

2. Use of the animal-derived lysozyme dimer according to claim 1 in the preparation of a preparation for inhibiting porcine reproductive and respiratory syndrome virus. Features: The preparation is a preparation for inhibiting the proliferation of porcine blue ear virus in cells.

3. Use of the animal-derived lysozyme dimer according to claim 2 in the preparation of a preparation for inhibiting porcine reproductive and respiratory syndrome virus. Features: The cells are MARC-145 cells.

4. A feed additive, Features: The feed additive comprises animal-derived lysozyme dimer, Chinese medicine extract and probiotics; the Chinese medicine is selected from one or two of astragalus, dandelion, purslane and honeysuckle; the probiotics is selected from one of lactobacillus, bacillus subtilis and bacillus licheniformis.

5. The feed additive according to claim 4, Features: The feed additive includes vitamin C; the mass ratio of the animal-derived lysozyme dimer to vitamin C is (3-5): (0.15-0.2).

6. The feed additive according to claim 4 or 5, Features: The feed additive includes gamma-aminobutyric acid; the mass ratio of the animal-derived lysozyme dimer to the gamma-aminobutyric acid is (3-5): (0.5-1).

7. The feed additive according to claim 4 or 5, Features: The feed additive comprises a biologically acceptable carrier; the carrier is selected from one of light calcium carbonate, calcium chloride, tricalcium phosphate, monocalcium phosphate, calcium lactate, calcium gluconate, calcium hydrogen phosphate, wheat bran, corn cob powder, saccharin, sorbitol, saccharin calcium, saccharin sodium, and sodium glutamate.

8. The feed additive according to claim 7, Features: The mass ratio of the animal-derived lysozyme dimer to the carrier is (3-5): (1.5-3.8).

9. The feed additive according to claim 4 or 5, Features: The number of viable bacteria in the probiotics is ≥10×10 11 cfu / g.

Citation Information

Cited By

  • Pregnant sow feed capable of increasing birth weight of piglets and improving placenta inflammation of sows

    CN120391577A